Sanofi Shares Fall 2.77% at Close, Approaching Major Technical Support
Sanofi shares closed at 77.54 euros this Wednesday, January 28, 2026, down 2.77% from the previous session. The pharmaceutical stock is now down 23.49% over one year and 12.02% over the last three months.
Current Stock Position and Technical Analysis
Sanofi's stock price stands at 77.54 euros, very close to the major support level identified at 77.52 euros. The stock is also trading below the lower Bollinger band set at 77.71 euros, a configuration that in technical analysis terms suggests an extension of the downward movement beyond the usual statistical range. The 20-session moving average is at 81.18 euros, placing the current price 4.48% below this short-term trend indicator. The 14-period Relative Strength Index (RSI) is at 40, which is considered neutral territory, between the oversold zone (30) and the median zone (50).
Neutral Rating Reaffirmed by Citigroup
Citigroup reaffirmed its neutral rating on the stock on January 27, 2026, with a target price set at 85.00 euros. This target is 9.62% above the current price. The company will publish its fourth-quarter results on Thursday, January 29, 2026. Future financial deadlines are scheduled for April 23, 2026 (first-quarter results), July 30, 2026 (semi-annual results), and October 30, 2026 (third-quarter results).
